Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV

BACKGROUND: Triple infection (TI) with HIV-1, HCV, and HBV (TI) is highly prevalent in intravenous drug users (IDUs). These TI patients have a faster progression to AIDS, and even after antiretroviral therapy (ART) the prognosis of their disease is poor. The use of microRNA (miRNA) to silence genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Khokhar, Ambreen, Noorali, Samina, Sheraz, Muhammad, Mahalingham, Kuha, Pace, Donald G., Khanani, Mohammad R., Bagasra, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535683/
https://www.ncbi.nlm.nih.gov/pubmed/23289041
http://dx.doi.org/10.3402/ljm.v7i0.19774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535683/
https://www.ncbi.nlm.nih.gov/pubmed/23289041
http://dx.doi.org/10.3402/ljm.v7i0.19774

Ejemplares similares